Wieland W. Wolf

Biography

CEO of ProBioGen since June 14, 2010. Dr Wieland W. Wolf regards the positioning of ProBioGen as a leading, science driven contract partner for biopharmaceutical development and production within a network of strategic alliances and cooperations as his pre-eminent task. Special emphasis is put on the further exploration of the excellent scientific expertise and the unique technological know-how, to the benefit of ProBioGen's customers. Looking back over three decades of biopharmaceutical experience, Wieland W. Wolf has held several positions in the biopharmaceutical industry. A biologist by education, he was involved in pioneering product registrations at Bioferon GmbH, headed a production unit for API and parenteral dosage forms at the same company, and was responsible for the biotechnology division of the Rentschler Group, which he led through its transformation from a product-oriented enterprise into an established service provider and contract manufacturing organization (CMO). He is the President of the European Association for Pharma Biotechnology and a member of the Board of Trustees of the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB, Stuttgart, Germany).

Research Interest

Biotechnology